228 × 210px · PNG
Source: press kit
Alloy Health Review (2026)
UnitedWellness Verdict
Alloy Health takes a clear, evidence-grounded approach to menopause care at one of the lowest price points in the category. Their protocols follow mainstream clinical guidelines for hormone therapy — FDA-approved medications and standard-of-care dosing — rather than leaning on compounded bioidentical marketing. For cost-conscious patients who want clinical credibility without a high monthly price tag, Alloy earns a serious look.
Best for: Cost-conscious patients who want evidence-based menopause care without the premium price tag and don’t need intensive clinical oversight.
Affiliate disclosure: If you sign up for Alloy Health through a link on this page, UnitedWellness may earn a commission. This does not affect our review. Full disclosure.
What is Alloy Health?
Alloy Health is a telehealth menopause care platform offering FDA-approved hormone therapy through a subscription model. Founded to improve access to quality menopause care for women who can’t easily reach a specialist, Alloy prescribes through licensed clinicians following evidence-based protocols and delivers medication directly to patients.
The platform is women-only and focused specifically on menopause — not a general telehealth service that adds menopause as one of many offerings. That focus keeps the protocols clean and the clinical approach consistent.
The evidence-based approach
Alloy’s approach is grounded in mainstream clinical guidelines rather than the compounded bioidentical hormone model that some competitors use as a differentiator. Their medications include estrogen patches, gels, creams, vaginal estrogen, and oral progesterone — all FDA-approved forms with well-established evidence bases.
This distinction matters because some marketing in the hormone health space implies that compounded bioidentical hormones are inherently safer or more effective than standard options. The evidence doesn’t support that claim. Alloy’s protocols are grounded in what the current clinical literature actually supports, which is a meaningful quality signal for patients trying to evaluate their options.
Cost
Alloy’s starting price runs approximately $45 to $99 per month as of March 2026, depending on medication type. That’s among the lowest starting prices in the online HRT space. The subscription model bundles the consultation and prescription management — follow-up visits are included rather than billed separately at each appointment.
Insurance acceptance is limited. Verify current compatibility directly with Alloy before enrolling. The lower cash-pay rate makes it accessible without insurance for many patients, which is part of the value proposition.
Pros and cons
Strengths
- Lower starting price than most HRT telehealth competitors
- Evidence-based FDA-approved protocols — not compounded alternatives
- Subscription model includes follow-up — no separate visit billing
- Menopause-focused platform, not a general telehealth service
Limitations
- Limited insurance compatibility
- Less intensive clinical relationship than Midi Health
- Women only — no male hormone programs
- Not appropriate if you specifically want compounded bioidentical hormones
Who Alloy Health is best for
Alloy fits patients who want clinically sound menopause treatment at a transparent, lower cost and don’t need intensive ongoing clinical oversight. If you’re relatively self-directed, your symptoms are moderate rather than severe, and you want evidence-based care without paying a premium for it, Alloy is a strong choice.
For patients with insurance who want a deeper clinical relationship, Midi Health is the better option. For patients who specifically want bioidentical compounded hormones, see our Winona review. See how all programs compare in our full HRT comparison.